Ishara Investments’s Biohaven BHVN Stock Holding History

Ishara Investments’s Portfolio BHVN Stock Details BHVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-88,000	Closed	-$994K	–	45
2025 Q4	$994K	Buy	+88,000	New	+$1.09M	1.14%	31

Other funds holding BHVN

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

IAM

Infinitum Asset Management Fort Lauderdale, Florida $983M AUM 26.53% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

RPSM

Royalty Pharma Sub-Manager New York $242M AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Ishara Investments's BHVN Position: Q1 2026 in Review

Ishara Investments sold out of Biohaven (BHVN) in Q1 2026, closing a stake of 88,000 shares — an estimated $994K sold.

Ishara Investments first reported a position in BHVN in Q4 2025 and held it in 1 quarter. The position peaked at $994K in Q4 2025. 277 funds tracked by Wall St. Rank hold BHVN as of Q1 2026.

Ishara Investments reported no remaining Biohaven position as of Q1 2026 after selling out during the quarter.
Ishara Investments sold 88,000 Biohaven shares in Q1 2026, an estimated $994K.
Ishara Investments first reported a position in Biohaven in Q4 2025 and held it in 1 quarter.
Ishara Investments's Biohaven position peaked at $994K in Q4 2025.
277 funds tracked by Wall St. Rank held Biohaven as of Q1 2026.

Based on Ishara Investments's 13F filing for Q1 2026, filed 15 May 2026.